Your browser doesn't support javascript.
loading
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesia.
Fryer, Ryan M; Harrison, Paul C; Muthukumarana, Akalushi; Nodop Mazurek, Suzanne G; Ng, Khing Jow; Chen, Rong Rhonda; Harrington, Kyle E; Dinallo, Roger M; Chi, Liguo; Reinhart, Glenn A.
Afiliación
  • Fryer RM; Department of Cardiometabolic Diseases, Boehringer-Ingelheim Pharmaceuticals, Inc, 900 Ridgebury Rd, Ridgefield, CT 06877-0368, USA. ryan.fryer@boehringer-ingelheim.
J Cardiovasc Pharmacol ; 59(4): 369-76, 2012 Apr.
Article en En | MEDLINE | ID: mdl-22179024

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Modelos Animales / Anestesia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Modelos Animales / Anestesia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2012 Tipo del documento: Article